After twenty-two days from the first injection, the CPX-LNP and CPX/p53-LNP groups had lower tumor volumes than the PBS, FLuc-LNP, and p53-LNP groups, with the co-therapy inducing the lowest tumor volume (Figure 5G). The gene discussed is TP53; the disease is neoplasm.